- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 13:48 | Catheter Precision secures up to $88M in strategic financing | 2 | Seeking Alpha | ||
| 13:06 | Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth | 86 | GlobeNewswire (Europe) | FORT MILL, S.C., March 11, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced transformational balance sheet improvements through new institutional capital commitments... ► Artikel lesen | |
| Di | Catheter Precision Jumps On Acquiring Fly Flyte From Creatd | - | RTTNews | ||
| Di | Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity | 1 | Seeking Alpha | ||
| Mo | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Catheter Precision, Inc.: Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 | 1 | GlobeNewswire (USA) | ||
| 19.02. | Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology | 1 | MassDevice | ||
| 19.02. | Catheter Precision Divests Non-Core Assets As It Shifts Focus | 1 | Benzinga.com | ||
| 19.02. | Catheter Precision, Inc.: Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth | 788 | GlobeNewswire (Europe) | FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive... ► Artikel lesen | |
| 17.02. | Catheter Precision acquires 20% stake in Creatd's aviation subsidiary | 1 | Investing.com | ||
| 17.02. | Catheter Precision steigt mit 20 % bei Luftfahrt-Tochter von Creatd ein | 2 | Investing.com Deutsch | ||
| 17.02. | CREATD INC.: VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. | 78 | GlobeNewswire (Europe) | Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy... ► Artikel lesen | |
| 17.02. | Catheter Precision, Inc.: VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. | 216 | GlobeNewswire (Europe) | Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital... ► Artikel lesen | |
| 12.02. | Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth | 1 | GlobeNewswire (USA) | ||
| 06.02. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Catheter Precision, Inc.: Catheter Precision Receives First Purchase Order for LockeT in Germany | 782 | GlobeNewswire (Europe) | FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 20.01. | Catheter Precision, Inc.: Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia | 4 | GlobeNewswire (USA) | ||
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 985 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,200 | -2,28 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Fresenius nach einem Treffen mit dem Finanzchef mit einem Kursziel von 57 Euro auf "Overweight" belassen. Die... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,250 | -0,86 % | Shortseller-Positionen aktuell: Brenntag, pbb, FMC, Ionos, Renk, Suss MicroTec, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,910 | -2,68 % | Eckert & Ziegler hebt Dividende um 29 Prozent auf 0,22 Euro an | Der Vorstand der Eckert & Ziegler SE plant für das Geschäftsjahr 2025 eine Dividende von 0,22 Euro je Aktie - ein Anstieg von 29 Prozent gegenüber dem splitbereinigten Vorjahreswert von 0,17 Euro. Die... ► Artikel lesen | |
| BICO GROUP | 1,681 | +1,27 % | BICO Group AB: BICO Group AB has divested the Finnish property for a total of EUR 3.5m | BICO Group AB ("BICO") has completed the divestment of its property in Oulu, Finland, through the sale of BICO Real Estate Oy to Logistea AB ("Logistea"). The total sales price amounts to EUR 3.5m,... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,100 | 0,00 % | Sernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 4, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) ("Sernova" or the "Company"), a leading regenerative medicine... ► Artikel lesen | |
| CARDINAL HEALTH | 186,05 | -0,53 % | Leerink Partners bekräftigt Outperform-Rating für Cardinal Health | ||
| RESMED | 206,90 | -2,77 % | RESMED INC: 144 Report of proposed sale of securities | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA 7300,B0Y,YAG: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZEROSTACK CORP.... ► Artikel lesen | |
| ZIMMER BIOMET | 78,74 | -0,35 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board... ► Artikel lesen | |
| UNIDOC HEALTH | 0,072 | -6,23 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results | Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements | SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented... ► Artikel lesen | |
| CYTOSORBENTS | 0,676 | -0,73 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| VERU | 2,480 | 0,00 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| CLARIANE | 3,774 | -2,98 % | Altenpflegedienst Korian lässt in Belgien 200 AC-Lader installieren | Korian Belgium, ein Anbieter von Altenpflegediensten, hat Blink Charging damit beauftragt, 200 Ladegeräte an 90 Korian-Standorten in ganz Belgien zu installieren. Blink Charging errichtet die Hardware... ► Artikel lesen |
Das Unternehmen CATHETER PRECISION INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,200 (-11,24 %) liegt der Kurs bei 1,580 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.